Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular alterations in bladder cancer.

C Cordon-Cardo1

  • 1Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

Cancer Surveys
|September 18, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial Expression of Concern: Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays.

British journal of cancer·2024
Same author

Involvement of tumor suppressors PTEN and p53 in the formation of multiple subtypes of liposarcoma.

Cell death and differentiation·2015
Same author

TSPYL2 is an essential component of the REST/NRSF transcriptional complex for TGFβ signaling activation.

Cell death and differentiation·2015
Same author

MicroRNA-126 inhibits invasion in bladder cancer via regulation of ADAM9.

British journal of cancer·2014
Same author

Targeting cancer stem cells to suppress acquired chemotherapy resistance.

Oncogene·2013
Same author

GAB2 induces tumor angiogenesis in NRAS-driven melanoma.

Oncogene·2012

Molecular genetic changes in bladder tumors are primary or secondary. Primary changes drive cancer genesis, affecting tumor grade and differentiation. Further research is needed to understand these bladder cancer molecular alterations.

Area of Science:

  • Oncology
  • Molecular Genetics
  • Cancer Biology

Background:

  • Bladder tumors exhibit primary and secondary molecular genetic alterations.
  • Primary alterations are crucial for cancer genesis, influencing tumor grade and differentiation.
  • Secondary alterations accumulate and contribute to tumor progression.

Purpose of the Study:

  • To classify and describe primary and secondary molecular genetic changes in bladder tumors.
  • To highlight the dual nature of primary alterations in low-grade versus high-grade tumors.
  • To emphasize the need for novel molecular approaches and validated clinical markers.

Main Methods:

  • Classification of molecular genetic aberrations in bladder neoplasms.
  • Review of existing evidence on genetic alterations and their impact on tumor biology.

Related Experiment Videos

  • Identification of key pathways (TP53, RB) involved in bladder cancer progression.

    • Main Results:

    • Primary alterations are linked to tumor genesis and can be categorized based on their effect on differentiation and cell death.
    • Low-grade tumors may involve chromosome 9 alterations, while high-grade tumors' initiation remains unclear.
    • Accumulation of genetic alterations, particularly in TP53 and RB pathways, is critical for tumor progression.

    Conclusions:

    • Understanding molecular genetic changes is vital for diagnosing and managing bladder cancer.
    • Further research, including molecular analyses of preneoplastic lesions, is required.
    • Translating molecular findings into clinical strategies is essential for improving patient outcomes.